Cohen; Jonathan Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cohen; Jonathan Marc.The latest application filed is for "oral formulations and lipophilic salts of methylnaltrexone".

Company Profile

0.10.16

Cohen; Jonathan Marc - Monroe NY
Cohen; Jonathan Marc - N/A
Cohen; Jonathan Marc - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20200121673 - Shah; Syed M. ; et al.	2020-04-23
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,507,206 - Shah , et al. Dec	2019-12-17
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190314365 - Shah; Syed M. ; et al.	2019-10-17
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,376,505 - Shah , et al. A	2019-08-13
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,307,417 - Shah , et al.	2019-06-04
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190117646 - Shah; Syed M. ; et al.	2019-04-25
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190117645 - Shah; Syed M. ; et al.	2019-04-25
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20160206612 - Shah; Syed M. ; et al.	2016-07-21
Oral formulations and lipophilic salts of methylnaltrexone Grant 9,314,461 - Shah , et al. April 19, 2	2016-04-19
Implantable Shunt Or Catheter Enabling Gradual Delivery Of Therapeutic Agents App 20160089521 - Dragoon; Deborah L. ; et al.	2016-03-31
Oral formulations and lipophilic salts of methylnal trexone Grant 8,956,651 - Shah , et al. February 17, 2	2015-02-17
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20140249171 - Shah; Syed M. ; et al.	2014-09-04
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20130330407 - SHAH; Syed M. ; et al.	2013-12-12
Oral formulations and lipophilic salts of methylnaltrexone Grant 8,524,276 - Shah , et al. September 3, 2	2013-09-03
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20120070495 - SHAH; Syed M. ; et al.	2012-03-22
Compositions Containing Piperacillin and Tazobactam Useful for Injection App 20110166091 - Cohen; Jonathan Marc ; et al.	2011-07-07
Compositions containing piperacillin and tazobactam useful for injection Grant 7,915,229 - Cohen , et al. March 29, 2	2011-03-29
Implantable Shunt Or Catheter Enabling Gradual Delivery Of Therapeutic Agents App 20110060265 - Dragoon; Deborah L. ; et al.	2011-03-10
Compositions Containing Piperacillin And Tazobactam Useful For Injection App 20090176720 - Cohen; Jonathan Marc ; et al.	2009-07-09
Compositions containing piperacillin and tazobactam useful for injection Grant 7,498,312 - Cohen , et al. March 3, 2	2009-03-03
Implantable shunt or catheter enabling gradual delivery of therapeutic agents App 20080051691 - Dragoon; Deborah L. ; et al.	2008-02-28
Compositions containing piperacillin and tazobactam useful for injection App 20060234995 - Cohen; Jonathan Marc ; et al.	2006-10-19
Compositions containing piperacillin and tazobactam useful for injection App 20060084639 - Cohen; Jonathan Marc ; et al.	2006-04-20
Compositions containing pipercillin and tazobactam useful for injection Grant 6,900,184 - Cohen , et al. May 31, 2	2005-05-31
Compositions containing pipercillin and tazobactam sodium useful for injection App 20040204372 - Cohen, Jonathan Marc ; et al.	2004-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.